Prolyl-tRNA synthetase inhibitor as a novel first-in-class keloid treatment: downregulation of de novo collagen synthesis and inflammatory cascade

瘢痕疙瘩 下调和上调 纤维化 癌症研究 污渍 免疫印迹 医学 免疫组织化学 病理 分子生物学 化学 生物 生物化学 基因
作者
Sally Min,Ki‐Myo Kim,Joseph Hwang,Jaewoo Kim,Jun Ho Park,Ji‐Ung Park,Caroline H. Lee,Ji‐Ung Park
出处
期刊:British Journal of Dermatology [Oxford University Press]
卷期号:193 (2): 298-309 被引量:5
标识
DOI:10.1093/bjd/ljaf140
摘要

BACKGROUND: Keloids are severe dermal fibrotic disorders caused by excessive deposition of collagen. Current therapies have high recurrence rates, and there is a clinical need for a new, fundamental approach. We focused on inhibiting proline, an essential amino acid for collagen biosynthesis. We developed DWN12088, a drug that downregulates prolyl-tRNA synthetase (PRS), an enzyme involved in proline ligation. OBJECTIVES: To investigate the antifibrotic activity of selective PRS inhibitors and elucidate the importance of DWN12088 as a first-in-class therapeutic agent for keloids. METHODS: Patient-derived keloid fibroblasts (KFs) and keloid tissues were obtained to observe PRS upregulation. In addition, the antifibrotic activity of selective PRS inhibitors was studied using KFs, and their treatment efficacy further validated in vivo using a KF xenograft severe combined immunodeficient (SCID) mouse model. Histological and immunohistochemistry analyses were performed with human-derived keloid tissues. Additional experiments included immunocytochemistry, cell viability analysis, migration analysis and Western blotting of KFs. Human KFs were injected into SCID mice to study nodule formation and histological characteristics. RESULTS: Compared with normal fibroblasts and healthy skin tissues, PRS was overexpressed in KFs and keloid tissues. A selective PRS inhibitor downregulated fibrotic markers, reduced migration capacity and lowered collagen production in KFs. In a KF xenograft SCID mouse model, a selective PRS inhibitor effectively suppressed keloid formation and mitigated inflammation and fibrosis. CONCLUSIONS: DWN12088, a selective PRS inhibitor, may be a novel first-in-class treatment modality that effectively prevents keloid development. Further clinical trials are required to verify the safety and clinical efficacy of PRS inhibitors for keloids. We believe that our study has applicability across several fibrotic wound problems such as hypertrophic scars.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
Mia123完成签到,获得积分10
1秒前
姿姿完成签到,获得积分10
2秒前
研友_LwlNdn的应助被未白采纳,获得10
2秒前
你说呢完成签到,获得积分10
2秒前
zzz发布了新的文献求助10
3秒前
张家璐发布了新的文献求助10
3秒前
3秒前
哇啦的应助被fanjunkk采纳,获得10
4秒前
4秒前
6秒前
xiaoxuey完成签到 ,获得积分10
6秒前
Enshin发布了新的文献求助10
6秒前
aXiong完成签到,获得积分10
6秒前
6秒前
6秒前
vvyuaan发布了新的文献求助10
9秒前
yang发布了新的文献求助10
12秒前
调皮的皓轩完成签到,获得积分10
13秒前
chenheng完成签到,获得积分10
13秒前
Enshin完成签到,获得积分10
13秒前
14秒前
16秒前
耍酷橘子完成签到,获得积分10
16秒前
香蕉觅云的应助被zzz采纳,获得10
17秒前
科研通AI6.3的应助被哈哈哈采纳,获得10
17秒前
Ava的应助被铁锤牛马版采纳,获得10
17秒前
17秒前
斯文败类的应助被糖油果子采纳,获得10
18秒前
19秒前
自知则知之完成签到,获得积分10
19秒前
张家璐完成签到,获得积分10
20秒前
20秒前
秃头沙师弟完成签到,获得积分10
21秒前
21秒前
糖糖发布了新的文献求助10
22秒前
明理熠彤完成签到,获得积分10
22秒前
奶龙王完成签到,获得积分10
23秒前
23秒前
MZ完成签到,获得积分10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187210
求助须知:如何正确求助?哪些是违规求助? 9575379
关于积分的说明 21840916
捐赠科研通 7784939
什么是DOI,文献DOI怎么找? 3434935
关于科研通互助平台的介绍 2559340
邀请新用户注册赠送积分活动 2481793